Clinical Trial Update: 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PF-00734200 in combination with metformin for Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-00734200

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED